Frequency Therapy System for Autologous Stem Cell Enhancement

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current stem cell therapies face limitations such as the need for complex and costly procedures, genetic rejection of transplanted stem cells, and the requirement for immunosuppressive drugs due to genetic differences between donors and recipients, which reduces their efficacy and safety.

Innovation Solution

Administration of a 0.6180 Hz continuous sine wave frequency through a frequency stimulation therapy system to enhance the production, release, and function of stem cells and their secretions from the patient's own genetically matched stem cells, eliminating the need for external cell sourcing and reducing the complexity of treatment protocols.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If transplanted stem cells are used from external donors, then stem cell therapy can be provided, but genetic rejection occurs and immunosuppressive drugs are required

Engineering Contradiction:

Improvestem cell availabilityVSAvoidtreatment safety

Core Design Contradiction:

Quantity of substanceVSReliability

Solution Approach 1:

The patent employs the patient's own stem cells (autologous stem cells) that are harvested, cultured, and re-administered to the same patient. This self-service approach eliminates the need for external donors and prevents genetic rejection, removing the requirement for immunosuppressive drugs while maintaining treatment safety and efficacy.

Inventive Principle:

Principle #25Self-service

2Quantity of substance

If complex stem cell procedures are used, then stem cell therapy can be administered, but treatment complexity and cost increase

Engineering Contradiction:

Improvestem cell therapy deliveryVSAvoidtreatment protocol complexity

Core Design Contradiction:

Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent extracts and cultures stem cells from the patient's own body (bone marrow or adipose tissue), processes them in a controlled environment to expand the stem cell population, and then re-administers them. This extraction and processing approach simplifies the overall treatment by using the patient's own cells rather than requiring complex matching procedures with external donors.

Inventive Principle:

Principle #2Taking out (Extraction)

Data Source

PatentUS11478656B2Apparatus for systemic human enhancement from administration of frequency therapy including enhanced stem cell and genetic therapy and methods for using same

Publication Date: 2022.10.25 SOUTER BLAIR A

AI summary

A systemic human repair and enhancement system that provides stem cell therapy utilizing an apparatus and methods for administering a treatment schedule of non-invasive and drug-free narrow and specific 0.6180 Hz frequency continuous sine wave therapy to the patient's cells. The frequency therapy may be in-vivo and in-vitro applications. The frequency therapy stimulates systemic stem cell production, particularly at a tissue sites having loss of function due to a condition, aging, damage, and or disease. The frequency therapy system encompasses a narrow and specific ultra-low continuous sine wave frequency stimulation therapy that produces one or more of the enhanced cell production, release, viability, proliferation, migration and or engraftment of the human patient's own genetically compatible stem cells, and the therapy enhances the stem cell's secretions thereby safely enhancing the secretion's therapeutic effects during stem cell therapy and simultaneously systemically enhancing the patient's pre-existing cells and tissues.